annb0t
Top 20
We feel now is a pretty good time to analyse Immutep Limited's (ASX:IMM) business as it appears the company may be on the cusp of a considerable accomplishment. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. The AU$227m market-cap company announced a latest loss of AU$32m on 30 June 2022 for its most recent financial year result. Many investors are wondering about the rate at which Immutep will turn a profit, with the big question be...
>>> Read more: Immutep Limited (ASX:IMM): When Will It Breakeven?
>>> Read more: Immutep Limited (ASX:IMM): When Will It Breakeven?
